e-learning
resources
2021
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Neutrophil-to-lymphocyte ratio, blood eosinophils and COPD exacerbations: a cohort study
Jens Ellingsen, Christer Janson, Kristina Bröms, Karin Lisspers, Björn Ställberg, Marieann Högman, Andrei Malinovschi
Source:
ERJ Open Res, 7 (4) 00471-2021; 10.1183/23120541.00471-2021
Journal Issue:
October
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jens Ellingsen, Christer Janson, Kristina Bröms, Karin Lisspers, Björn Ställberg, Marieann Högman, Andrei Malinovschi. Neutrophil-to-lymphocyte ratio, blood eosinophils and COPD exacerbations: a cohort study. ERJ Open Res, 7 (4) 00471-2021; 10.1183/23120541.00471-2021
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
The relationship between blood neutrophils, blood eosinophils and exacerbations of COPD – Results from the TIE-study
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Neutrophil-to-lymphocyte ratio and COPD exacerbations in the TIE-study
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020
Clinical factors associated with baseline blood eosinophils among patients with asthma or COPD: NOVELTY study
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020
Exacerbations in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS, NHLBI) are associated with sputum eosinophilia but not blood eosinophilia
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Neutrophil to lymphocyte ratio and severity of COPD : prospective study
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
Relationship of blood eosinophil count to exacerbations in COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016
QVA149 compared with salmeterol/fluticasone (SFC) on exacerbations and its correlation with baseline blood eosinophils: A pooled analysis of LANTERN and ILLUMINATE
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
Effect of indacaterol/glycopyrronium (IND/GLY) vs salmeterol/fluticasone (SFC) on moderate or severe COPD exacerbations and lung function based on baseline blood eosinophil counts: Results from the FLAME study
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016
The relationship between blood eosinophils and bacterial load in COPD patients
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Relationship between blood eosinophil count (Eos), clinical characteristics and mortality of patients with COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Pharmacodynamic effect of benralizumab on blood basophils and serum biomarkers in adults with COPD with sputum eosinophilia
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015
The trend of pulmonary function tests over time in COPD patients with different levels of blood eosinophils
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Blood vs sputum eosinophils as predictors of exacerbations in a cohort of severe asthmatics
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018
Can blood eosinophils predict sputum eosinophils in stable COPD?
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
Blood eosinophils and exacerbation rate in COPD patients over three years
Source: International Congress 2018 – Biomarkers and lung function in airway disease
Year: 2018
Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study
Source: ERJ Open Res, 4 (3) 00022-2018; 10.1183/23120541.00022-2018
Year: 2018
Increased circulating alveolar epithelial microparticles in COPD patients
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Stability of blood eosinophilia and neutrophil-to-lymphocyte ratio in COPD
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018
Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities.
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018
Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept